Follow WOWNEWS 24x7 on:
Shilpa Medicare Ltd has announced the launch of NorUDCA tablets in India, the world’s first approved treatment for Non-Alcoholic Fatty Liver Disease (NAFLD). This breakthrough addresses a vast unmet medical need, as NAFLD affects over 188 million people in India alone. Shilpa Medicare pioneers a new chapter in liver health management with this innovative dual-action therapy.
Show moreStay Ahead – Explore Now! Nifty 50 Rises 0.75%, Extends Winning Streak Amid Broad-Based Sectoral Gains
Follow WOWNEWS 24x7 on:
Copyright 2024 WOWNEWS 24x7. All rights reserved. The WOWNEWS 24x7 is not responsible for the content of external sites. Read about our approach to external linking.
Powered By Just Imagine
